Aura Biosciences, Inc. (AURA:NASDAQ) closed at $6.87 on November 20, 2026, down 1.58% on the day. The stock trades 27.9% below its 52-week high of $9.54 and 45.2% above its 52-week low of $4.73. Over the past year, it gained 24.9%. Aura Biosciences, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, AURA closed higher on 113 days (45%). Its best day was May 4, 2026 (+19.12%) and its worst was July 6, 2026 (-8.40%). The stock moved 10% or more in a single session 6 times.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.
Find more stocks like AURA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.